BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//bioPmed - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://biopmed.eu/en/
X-WR-CALDESC:Events for bioPmed
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20240206T113000
DTEND;TZID=Europe/Rome:20240206T123000
DTSTAMP:20260410T214529
CREATED:20240116T114831Z
LAST-MODIFIED:20240116T114831Z
UID:11425-1707219000-1707222600@biopmed.eu
SUMMARY:The new Patent Box\, overcompensation of R&D costs
DESCRIPTION:A webinar dedicated to companies wishing to explore the opportunities offered by the new Patent Box. In this meeting\, we will analyze how tax breaks can enhance the competitiveness of businesses\, focusing on the benefits of increased deduction of R&D costs for goods such as industrial patents\, copyrighted software\, models and designs. \nRegister \nGoals\nThe webinar is aimed at businesses and is designed to introduce tax breaks aimed at supporting the competitiveness of businesses. In particular it will be the New Patent Box\, optional scheme that allows an increased deduction of R&D costs incurred for the creation\, development\, enhancement\, maintenance and protection of goods covered by industrial patents\, copyrighted software\, models and designs. \nTarget group\nAll entities with business income carrying out Research\, Development and Innovation activities.  \nWhat we learn from the course\nThrough the course you will have the opportunity to deepen the reference legislation\, in relation to: objectives\, starting date of the increase\, eligible costs\, mechanism to bear costs\, cumulation\, appropriate documentation. \nProgram\n\nState of the art on tax incentives: Tax credit Research\, Development and Technological Innovation; Tax Credit Capital Goods 4.0 and new Transition 5.0; New Patent Box.\nNew Patent Box: characteristics of the facility. \nThe concept of Investor; Eligible intangible assets; Relevant assets; Eligible expenses.\nApplication schemes; reward mechanism. \n\nInformation and benefits\nThe New Patent Box aims to encourage:  \n\n Increasing the competitiveness of Italian companies\, through research and innovation activities • The protection of research results \n The maintenance in Italy of the derived assets from the search \n The use and exploitation of research results\n\nLecturer \nMaria Cristina Giacobbo Scavo\, CEO Value Services SpA.Graduated in Economics at the University of Studies “la Sapienza” in 1994\, Dott.ssa accountant and auditor\, she worked until 2000 as Audit Manager in PwC of Italian and international groups and as an expert in Risk Management in the telco field.  Since 2000 in Value Services\, he has managed more than 150 projects\, coordinating a team of over 25 professionals\, on facilitated European\, national and regional finance for research and development projects\, productive investments and internationalization plans. He is currently following large investment programs for industrial and multinational groups. Since 2010 it also coordinates the European team dedicated to supporting companies and in particular SMEs and innovative startups in the implementation and implementation of growth plans\, identifying the most appropriate forms of corporate finance in the form of facilitated finance\, and equity instruments. Maria Cristina Giacobbo Scavo also has a track record of successful experiences in risk capital management in SMEs operating in the medical\, biotechnology\, ICT and advanced mechanics sectors. \nRegister
URL:https://biopmed.eu/en/evento-en/the-new-patent-box-overcompensation-of-rd-costs/
LOCATION:Online
CATEGORIES:bioPmed events
ATTACH;FMTTYPE=image/png:https://biopmed.eu/wp-content/uploads/2024/01/NuovoPatentBox-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20240227T113000
DTEND;TZID=Europe/Rome:20240227T123000
DTSTAMP:20260410T214529
CREATED:20240212T111515Z
LAST-MODIFIED:20240212T111515Z
UID:11424-1709033400-1709037000@biopmed.eu
SUMMARY:Innovation and sustainability: the importance of thinking about the future
DESCRIPTION:Are you interested in exploring the latest innovations in the biotech and pharma sector\, with an eye to environmental sustainability? Join our webinar dedicated to professionals and professionals in the fields of Cell Factory\, Biotech\, pharma and hospital. A unique opportunity to explore the ecological impact of ATMP manufacturing\, compare innovative technologies and discuss European regulations in favor of sustainability. \nRegister \nTarget group\nThe webinar is aimed at all stakeholders and especially people working in the fields of Cell Factory\, Biotech \, pharma and hospitals. \nWhat we learn from the course\nDuring the meeting will be proposed ideas for reflection on the assessment of the ecological impact and environmental sustainability. In particular\, through the sharing of experiences\, ATMP manufacturing issues will be addressed in the comparison between the traditional cell factory and cell factory that uses innovative technology such as closed systems.\nThen there will be ideas for reflection on how fundamental is the use\, also in the health sector\, of sustainable products. In this regard\, we will talk about the European regulation that encourages companies to take sustainable measures and the prohibition of the use of formaldehyde. \nProgram\n\nDescription of entrepreneurial paths as a virtuous example of companies that have invested in the development of a sustainable product.\nGMP Regulatory Scope for ATMP.\nDefinition Open and closed systems for ATMP manufacturing.\nOpen system comparison (ainb) vs Closed AinD.\nEnvironmental sustainability in ATMP manufacturing in closed systems.\nOutline of European regulations that guide business choices towards a greater commitment to sustainability.\n\nLecturers\n\nAvv. Giorgia Pansa. He is a lawyer and\, since 2020\, he actively collaborates with Addax Biosciences\, taking care of the communication activities of the project\, whose objective is to safeguard the health of workers professionally exposed to formalin\, aiming to replace the carcinogen with a safe and sustainable fixative.\nDoct. Cristina Zanini. After graduating in Chemistry and a Master in Clinical Biochemistry and Molecular Medicine (2003)\, he obtained a doctorate in Biochemistry and Cellular Biotechnology (University of Turin\, 2007). Head of a Research and Development laboratory located within the University of Turin; he is also a contact person for the organization of training\, workshops\, webinars and scientific meetings in the field of ATMP. She has published more than 20 articles and is the author of 4 different patents presented in collaboration with the University of Turin\, Euroclone and bioair.\n\nRegister
URL:https://biopmed.eu/en/evento-en/innovation-and-sustainability-the-importance-of-thinking-about-the-future/
LOCATION:Online
CATEGORIES:bioPmed events
ATTACH;FMTTYPE=image/png:https://biopmed.eu/wp-content/uploads/2024/02/1.png
END:VEVENT
END:VCALENDAR